HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%- hyaluronic acid sodium salt 2% / mometasone furoate 0.1% / niacinamide 4% cream 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%

Directions for use

b

Sincerus Florida, LLC adverse reactions.

s

Active, inactive

s

NDC 72934-2098-2
HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%
Cream 30gm

d

HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4% 
hyaluronic acid sodium salt 2% / mometasone furoate 0.1% / niacinamide 4% cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-2098
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYALURONIC ACID (UNII: S270N0TRQY) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONIC ACID2 g  in 100 g
MOMETASONE FUROATE (UNII: 04201GDN4R) (MOMETASONE - UNII:8HR4QJ6DW8) MOMETASONE FUROATE0.1 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-2098-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/21/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/21/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-2098)

Revised: 5/2019
Document Id: 8967cd2b-c0a5-8df1-e053-2a95a90a3670
Set id: 8967cd2b-c0a4-8df1-e053-2a95a90a3670
Version: 1
Effective Time: 20190521
 
Sincerus Florida, LLC